|Product name||Amoxicillin dry suspension|
|Pregnancy classification||FDA Pregnancy Rating:B|
|Lactation grading||Amoxicillin:L1, half-life 1.7h less than 0.95% maternal dose into the milk|
|Medicine interactions||1.Probenecid competitively reduces the secretion of the renal tubules of the product, and the simultaneous application of both can cause an increase in the blood concentration of amoxicillin and an increase in half-life.|
2.Chloramphenicol, macrolides, sulfonamides and tetracyclines interfere with the antibacterial effect of amoxicillin in vitro, but its clinical significance is unknown.
Amoxicillin dry suspension, the indication is amoxicillin for the following infections caused by sensitive bacteria (non-beta lactamase producing strain):1.Upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, and tonsillitis caused by hemolytic streptococcus, Streptococcus pneumoniae, Staphylococcus or Haemophilus influenzae.2.Genitourinary tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis.3.Skin and soft tissue infections caused by hemolytic streptococcus, staphylococcus or Escherichia coli.4.Lower respiratory tract infections such as acute bronchitis and pneumonia caused by Streptococcus hemolyticus, Streptococcus pneumoniae, Staphylococcus or Haemophilus influenzae.5.Acute simple gonorrhea.6.This product can also be used to treat typhoid,typhoid carriers and leptospirosis;Amoxicillin can also be combined with clarithromycin and lansoprazole to eradicate stomach, duodenal Helicobacter pylori, reduce the recurrence rate of digestive ulcer .This product is a sugar-free (sucrose, glucose) formula, especially suitable for children.for Export Only